×

Diacylglycerol Acyltransferase Inhibitors

  • US 20090105273A1
  • Filed: 05/01/2008
  • Published: 04/23/2009
  • Est. Priority Date: 05/22/2007
  • Status: Active Grant
First Claim
Patent Images

1. A compound of formula (I):

  • wherein;

    R1 is phenyl or 5- or 6-membered heteroaryl, said phenyl and heteroaryl being unsubstituted or substituted with halogen, lower alkyl, alkoxy or O—

    CF3;

    R2 is halogen, lower alkyl, haloloweralkyl or alkoxy;

    R3 is nitrogen, oxygen or absent, said nitrogen being unsubstituted or substituted with lower alkyl;

    R4 is carbon, nitrogen, oxygen or absent, said carbon or nitrogen being unsubstituted or substituted with lower alkyl,wherein both R3 and R4 are not absent;

    R5 is -loweralkyl,-alkoxy,-hydroxy,-amine,-lower alkyl amine,-haloloweralkyl,-lower alkoxy,-lower alkenyloxy,-cycloloweralkyl, unsubstituted or substituted with one to four substituents from loweralkyl, hydroxy, halogen, —

    C(O)OH, —

    C(O)O-lower alkyl or —

    C(O)O-lower alkyl-phenyl,-5- or 6-membered heterocycloalkyl, unsubstituted or substituted, with one to four substituents from lower alkyl, hydroxy, halogen, —

    SO2-loweralkyl, —

    C(O)OH, —

    C(O)O-lower alkyl or —

    C(O)O-lower alkyl-phenyl,-5- or 6-membered aryl, unsubstituted or substituted with one to four substituents from lower alkyl, hydroxy, halogen, —

    C(O)OH, —

    C(O)O-lower alkyl or —

    C(O)O-lower alkyl-phenyl,-5- or 6-membered heteroaryl, unsubstituted or substituted with one to four substituents from lower alkyl, hydroxy, halogen, —

    C(O)OH, C(O)O-lower alkyl or —

    C(O)O-lower alkyl-phenyl,—

    (CH2)nC(O)OH,—

    CH2C(lower alkyl)2C(O)OH,—

    CH2(cycloalkyl)C(O)OH,-(cycloalkyl)C(O)OH,—

    CH2C(CH3)3,—

    (CH2)n-cycloalkyl,-cycloalkenyl,-bicycloalkenyl-C(O)OH,—

    (CH2)n

    O-alkyl,—

    O—

    C(═

    C)-lower alkyl,—

    O—

    (CH2)n-phenyl,—

    NSO2-loweralkyl,—

    NSO2-cycloalkyl,—

    NSO2-aryl,—

    N-lower alkyl,—

    N-cycloalkyl, said cycloalkyl being unsubstituted or substituted with —

    C(O)OH,—

    N-heterocycloalkyl,—

    N-aryl,—

    N—

    (CH2)n-aryl,—

    N-heteroaryl, said heteroaryl being unsubstituted or substituted with alkyl,—

    N—

    CH(lower alkyl)C(O)OH,—

    N-(cycloalkyl)C(O)OH,—

    N—

    CH(lower alkyl)C(O)O-lower alkyl,-phenyl-C(O)OH,X is 5- or 6-membered aryl or 5- or 6-membered heteroaryl, said aryl or heteroaryl being unsubstituted or substituted with lower alkyl, halogen or cyano;

    Y is phenyl, heteroaryl, cycloloweralkyl, or 5- or 6-membered heterocycloalkyl, —

    N(CH2)n)N—

    , said phenyl, cycloloweralkyl or heterocycloalkyl being unsubstituted or substituted with lower alkyl, halogen or cyano; and

    n is 1, 2 or 3,or pharmaceutically acceptable salts thereof,

View all claims
  • 5 Assignments
Timeline View
Assignment View
    ×
    ×